• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌-吡唑配合物的合成、表征及抗癌活性。

Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.

机构信息

Department of Chemistry, University of Louisiana at Lafayette, LA 70504, USA. .

出版信息

J Inorg Biochem. 2012 Jun;111:33-9. doi: 10.1016/j.jinorgbio.2012.02.022. Epub 2012 Mar 4.

DOI:10.1016/j.jinorgbio.2012.02.022
PMID:22484498
Abstract

A series of new water soluble Ru(III) pyrazole complexes mer-[RuCl(3)(DMSO-S)(pyz)(2)] 1, mer-[RuCl(3)(DMSO-S)(DMSO-O)(pyz)] 2, mer-[RuCl(3)(bpy)(dmpyz)] 3, and mer-[RuCl(3)(DMSO-S)(dmpyz)(2)] 4 (pyz=pyrazole; dmpyz=3,5-dimethylpyrazole, bpy=2,2'-bipyridine) have been synthesized and characterized by use of a combination of spectroscopy (IR and UV-visible), X-ray diffraction, and cyclic voltammetry. The molecular X-ray structure of all reported compounds (1-4) revealed distorted octahedral coordination around ruthenium. The cytotoxicity assay on human breast cancer cells (MCF7) demonstrated that compounds 1 and 4 affect cell viability, whereas compounds 2 and 3 do not show appreciable activity. The IC(50) values for 1 and 4 lie within the range of 71-32μM in MCF7 cells.

摘要

一系列新的水溶性 Ru(III)吡唑配合物 mer-[RuCl(3)(DMSO-S)(pyz)(2)] 1、mer-[RuCl(3)(DMSO-S)(DMSO-O)(pyz)] 2、mer-[RuCl(3)(bpy)(dmpyz)] 3 和 mer-[RuCl(3)(DMSO-S)(dmpyz)(2)] 4(pyz=吡唑;dmpyz=3,5-二甲基吡唑,bpy=2,2'-联吡啶)已通过光谱(IR 和 UV-可见)、X 射线衍射和循环伏安法的组合进行了合成和表征。所有报道的化合物(1-4)的分子 X 射线结构显示钌周围的扭曲八面体配位。对人乳腺癌细胞(MCF7)的细胞毒性测定表明,化合物 1 和 4 影响细胞活力,而化合物 2 和 3 没有表现出明显的活性。化合物 1 和 4 在 MCF7 细胞中的 IC(50)值在 71-32μM 范围内。

相似文献

1
Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.钌-吡唑配合物的合成、表征及抗癌活性。
J Inorg Biochem. 2012 Jun;111:33-9. doi: 10.1016/j.jinorgbio.2012.02.022. Epub 2012 Mar 4.
2
In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.涉及 6-苄基氨基嘌呤衍生物的 Ru(III) 配合物的体外和体内生物活性筛选,其促凋亡活性高于 NAMI-A。
J Inorg Biochem. 2011 Jul;105(7):937-48. doi: 10.1016/j.jinorgbio.2011.04.002. Epub 2011 Apr 12.
3
New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.新型π-芳环钌(II)钢琴凳配合物与氮配体
J Inorg Biochem. 2012 Apr;109:72-81. doi: 10.1016/j.jinorgbio.2012.01.003. Epub 2012 Jan 20.
4
Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.具有大体积三唑并嘧啶配体的两种高细胞毒性钌(III)配合物的合成、表征及抗肿瘤活性。
Dalton Trans. 2013 May 7;42(17):6219-26. doi: 10.1039/c2dt32216a. Epub 2013 Jan 18.
5
Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.具有螯合 P 功能化烷基苯基硫醚和亚砜配体的阳离子芳烃钌(II)配合物作为有效的抗癌剂。
Dalton Trans. 2013 Mar 21;42(11):3771-4. doi: 10.1039/c3dt33064h. Epub 2013 Jan 23.
6
Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and in vitro anticancer activity.羧酸官能团对钌(II)多吡啶配合物与 DNA 结合、细胞毒性和抗氧化活性的影响:合成、结构和体外抗癌活性。
Eur J Med Chem. 2013 Jan;59:253-64. doi: 10.1016/j.ejmech.2012.11.024. Epub 2012 Nov 27.
7
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.新型半三明治型 Ru(II) 配位化合物,其特征为 fac-Ru(dmso-S)3 片段:面封基团对化学行为和体外抗癌活性的影响。
Dalton Trans. 2011 Oct 7;40(37):9533-43. doi: 10.1039/c1dt11043h. Epub 2011 Aug 19.
8
Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.高活性中性钌(II)芳环配合物的合成、表征及其抗癌性能研究。
J Inorg Biochem. 2012 Aug;113:77-82. doi: 10.1016/j.jinorgbio.2012.04.003. Epub 2012 Apr 12.
9
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.用于抗癌活性的钌-卟啉缀合物的合成策略。
Dalton Trans. 2009 Dec 28(48):10742-56. doi: 10.1039/b911393b. Epub 2009 Aug 27.
10
Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.标题:作为共配体的苯并噻唑衍生物的铱(III)和 fac Ru(III)三苯基膦配合物的合成、X 射线结构、物理化学性质和抗癌活性。
Dalton Trans. 2019 Jul 16;48(28):10689-10702. doi: 10.1039/c9dt01803d.

引用本文的文献

1
Modified magnetic chitosan with mono(6-amino-6-deoxy)-β-cyclodextrin as a novel catalyst toward the synthesis of pyrazolopyranopyrimidines and pyrano[2,3-c]pyrazole-3-carboxylates.以单(6-氨基-6-脱氧)-β-环糊精修饰的磁性壳聚糖作为一种新型催化剂用于合成吡唑并吡喃嘧啶和吡喃并[2,3-c]吡唑-3-羧酸酯。
Sci Rep. 2025 Mar 6;15(1):7863. doi: 10.1038/s41598-025-92249-5.
2
Pyrazoles as Anti-inflammatory and Analgesic Agents: and Studies.吡唑类化合物作为抗炎和镇痛药物:构效关系和作用机制研究。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(1):39-51. doi: 10.2174/0118715230275741231207115011.
3
Synthesis, characterization, biological potency, and molecular docking of Co, Ni and Cu complexes of a benzoyl isothiocyanate based ligand.
基于苯甲酰异硫氰酸酯配体的 Co、Ni 和 Cu 配合物的合成、表征、生物效价和分子对接。
Sci Rep. 2024 May 1;14(1):10032. doi: 10.1038/s41598-024-58108-5.
4
Synthesis and cytotoxicity against tumor cells of pincer N-heterocyclic ligands and their transition metal complexes.钳形氮杂环配体及其过渡金属配合物的合成与对肿瘤细胞的细胞毒性
RSC Adv. 2021 Oct 27;11(55):34742-34753. doi: 10.1039/d1ra05918a. eCollection 2021 Oct 25.
5
The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods.使用对接方法研究含双吡唑、联吡啶和菲咯啉部分的一些含氮供体配体的抗癌活性。
Bioinorg Chem Appl. 2018 Jun 4;2018:5796287. doi: 10.1155/2018/5796287. eCollection 2018.
6
Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.用于肿瘤靶向药物递送的钌配合物功能化纳米结构材料的最新进展。
Int J Nanomedicine. 2017 Apr 4;12:2749-2758. doi: 10.2147/IJN.S131304. eCollection 2017.